OOIR: Observatory of International Research

Papers

(The TQCC of Hematology-Oncology Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Prognostic and Predictive Implications of Cytogenetics and Genomics	116
Autoimmune Hemolytic Anemia: An Old Disease with New Twists	62
Managing First-Line Metastatic Renal Cell Carcinoma	54
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver	53
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia	35
Conflict and Access to Health Care	35
Insights into Renal Cell Carcinoma with Novel Imaging Approaches	33
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia	29
Clinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis	28
Cancer of the Larynx and Hypopharynx	28
Treatment of High-Risk Gestational Trophoblastic Neoplasia	28
Contents	27
Contributors	26
Benefits and Harms of Interception and Early Detection of Cancer	25
Hematology/Oncology Clinics of North America	25
Copyright	23
Contributors	23
Future Directions for Gestational Trophoblastic Disease	22
Updates in the Management of Warm Autoimmune Hemolytic Anemia	21
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer	21
Factor XIII Deficiency	20
The Evolving Landscape of Drug Therapies for Sickle Cell Disease	20
Advances in Gastric Cancer Surgical Management	19
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes	18
Advances in Immunotherapy in Esophagogastric Cancer	17

Disparities in Breast Cancer Outcomes and How to Resolve Them	17
Forthcoming Issues	16
Emerging Therapies in β-Thalassemia	14
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas	14
Advances in Surgical Techniques for Lung Cancer	14
Inherited Platelet Disorders	14
Clinical Characteristics and Treatment of Histiocytic Disorders in Children	13
The Need for Translational Epidemiology in Beta Thalassemia Syndromes	13
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma	13
Histiocytic Disorders in Pediatric and Adult Patients	13
The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia	13
Advances in Systemic Therapy in Pancreatic Cancer	13
Genomic Alterations in Langerhans Cell Histiocytosis	13
Contents	13
Foreword	13
Adult Evans' Syndrome	12
Forthcoming Issues	12
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia	12
Liposarcoma	12
Red Cell Antigens and Antibodies	12
New Developments in Myeloma	11
Clinical Vignettes Part I	11
Evaluation and Management of Bing–Neel Syndrome	11
Hereditary Renal Cell Carcinoma Syndromes	11
The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors	11
Genes as Medicine	11
Skin Cancer Precursors	11
Copyright	11
Genomics of Resistance to Targeted Therapies	11
Gestational Trophoblastic Neoplasia	10
Malignancies of the Upper Gastrointestinal Tract	10
Contents	10
CAR T Cells: Past Successes, Current Limitations, and Future Opportunities	10
Copyright	9
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy	9
High-Risk Non-Melanoma Skin Cancers	9
Local Control in Soft Tissue Sarcomas	9
Heavy Ion Particle Therapy in Modern Day Radiation Oncology	9
Patient-Reported Outcomes in Radiation Oncology	9
Bispecific Antibodies in the Treatment of Multiple Myeloma	8
Contents	8
Evolution of Gene Therapy, Historical Perspective	8
Copyright	8
Disparities and Inequities Among Patients with Central Nervous System Tumor	8
Advances in the Surgical Management of Esophageal Cancer	8
Melanoma Brain Metastasis	8
Forthcoming Issues	8
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma	7
Radiation-Induced Tissue Regeneration	7
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer	7

Breast Cancer and Lifestyle Factors	7
Contents	7
Breast Cancer in India	7
Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms	7
Copyright	6
Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers	6
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors	6
Chronic Lymphocytic Leukemia	6
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?	6
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies	6
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases	6
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma	6
Disorders of Fibrinogen and Fibrinolysis	5
Education and Training Models for Remote Learning	5
Hemophilia A/B	5
Contents	5
Merkel Cell Carcinoma	5
Sarcomas	5
Copyright	5
Targeted Therapy Innovations for Melanoma	5
Impact of Clonal Heterogeneity in Multiple Myeloma	5
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy	5
Ductal Carcinoma In Situ	5
Contributors	5
Pathogenic Mechanisms in Thalassemia II	5
Pathogenic Mechanisms in Thalassemia I	5
Early Detection of Precursor Diseases of Multiple Myeloma	5
Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton’s Tyrosine Kinase Inhibitors	5
FLASH Radiotherapy	5
Clinical Complications and Their Management	5
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma	5
Immune-Pathogenesis of Myeloma	5
Genetics and Genomics of Gestational Trophoblastic Disease	5
When Is It Important to Sequence Sarcomas and Other Mesenchymal Neoplasms? A Practical Guide to Molecular Testing	5
Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors	4
Role of Radiation in Treatment of Renal Cell Carcinoma	4
The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia	4
Contents	4
Immunotherapy-associated Autoimmune Hemolytic Anemia	4
Remembering the Contributions of Professor David J. Weatherall	4
Management of Waldenström Macroglobulinemia in Limited-Resource Settings	4
Complications of Autoimmune Hemolytic Anemia	4
Contributors	4
Forthcoming Issues	4
Renal Cell Cancer	4
Approach to High-Risk Multiple Myeloma	4
Local Therapies in Advanced Colorectal Cancer	4
Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)	4
Regulatory Aspects of Gene Therapy	4
Waldenström Macroglobulinemia	4
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia	4
Contributors	4
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis	4
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia	4